WO2004098566A3 - Chewable lozenge cold remedy composition and method for making same - Google Patents

Chewable lozenge cold remedy composition and method for making same Download PDF

Info

Publication number
WO2004098566A3
WO2004098566A3 PCT/US2004/013421 US2004013421W WO2004098566A3 WO 2004098566 A3 WO2004098566 A3 WO 2004098566A3 US 2004013421 W US2004013421 W US 2004013421W WO 2004098566 A3 WO2004098566 A3 WO 2004098566A3
Authority
WO
WIPO (PCT)
Prior art keywords
making same
chewable lozenge
cold remedy
remedy composition
composition
Prior art date
Application number
PCT/US2004/013421
Other languages
French (fr)
Other versions
WO2004098566A2 (en
Inventor
Tim Clarot
Original Assignee
Zicam Llc
Tim Clarot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zicam Llc, Tim Clarot filed Critical Zicam Llc
Priority to US10/556,739 priority Critical patent/US20070092552A1/en
Publication of WO2004098566A2 publication Critical patent/WO2004098566A2/en
Publication of WO2004098566A3 publication Critical patent/WO2004098566A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds

Abstract

A chewable lozenge for the treatment of cold symptoms having a zinc formulation which includes both zinc gluconate and zinc actetate.
PCT/US2004/013421 2003-04-30 2004-04-30 Chewable lozenge cold remedy composition and method for making same WO2004098566A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/556,739 US20070092552A1 (en) 2003-04-30 2004-04-30 Chewable lozenge cold remedy composition and method for making same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46701003P 2003-04-30 2003-04-30
US60/467,010 2003-04-30

Publications (2)

Publication Number Publication Date
WO2004098566A2 WO2004098566A2 (en) 2004-11-18
WO2004098566A3 true WO2004098566A3 (en) 2004-12-23

Family

ID=33435008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/013421 WO2004098566A2 (en) 2003-04-30 2004-04-30 Chewable lozenge cold remedy composition and method for making same

Country Status (2)

Country Link
US (1) US20070092552A1 (en)
WO (1) WO2004098566A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
US11517523B2 (en) 2017-09-12 2022-12-06 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
JP2022524486A (en) * 2019-03-14 2022-05-06 イントラモント テクノロジーズ，インコーポレイテッド Preparations for the prevention of diseases that occur through the oral cavity and pharynx

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US6139864A (en) * 1998-04-28 2000-10-31 Sudzucker Aktiengesellschaft Compositions for common colds

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138477A (en) * 1976-05-28 1979-02-06 Colgate Palmolive Company Composition to control mouth odor
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US5095035A (en) * 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
US5286748A (en) * 1981-01-05 1994-02-15 Eby Iii George A General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
USRE33465E (en) * 1981-07-31 1990-11-27 Method for reducing the duration of the common cold
US4758439A (en) * 1984-06-11 1988-07-19 Godfrey Science & Design, Inc. Flavor of zinc supplements for oral use
FR2574295B1 (en) * 1984-12-07 1988-02-26 Rech Etu Therapeutiques ZINC GLUCONATE MEDICINES USEFUL FOR THE TREATMENT OF HYPERPROLACTINEMIA
US4689214A (en) * 1985-04-16 1987-08-25 Colgate-Palmolive Company Composition to counter breath odor
US4867989A (en) * 1986-09-09 1989-09-19 Warner-Lambert Company Chewing gum mineral supplement
US5059416A (en) * 1989-06-26 1991-10-22 Warner-Lambert Company Zinc compound delivery system with improved taste and texture
US5075291A (en) * 1989-11-22 1991-12-24 Ici Americas Inc. Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
GB8928196D0 (en) * 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
US5094845A (en) * 1991-03-04 1992-03-10 David G. Vlock Oral compositions containing zinc gluconate complexes
US5165914A (en) * 1991-03-04 1992-11-24 David G. Vlock Oral compositions containing zinc lactate complexes
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
US5989574A (en) * 1996-09-13 1999-11-23 Slavin; Andrew B. Weight loss compound and method of using
WO1998011867A1 (en) * 1996-09-20 1998-03-26 Warner-Lambert Company Oral compositions containing a zinc compound
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
NZ335780A (en) * 1996-10-23 2001-01-26 Univ New York State Res Found Compositions to control oral microbial oxidation-reduction (Eh) levels and treat gingivitis-periodontitis
US5897891A (en) * 1996-11-18 1999-04-27 Godfrey; John C. Flavorful zinc compositions for oral use incorporating copper
US6030605A (en) * 1997-04-03 2000-02-29 Nabisco, Inc. Breath freshening compositions and methods using them
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
US6169118B1 (en) * 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6280769B1 (en) * 1999-09-13 2001-08-28 Nabisco, Inc. Breath freshening comestible product
US20010018077A1 (en) * 2000-01-24 2001-08-30 Shaner Edward O. Herbal formulation for stimulating the immune system to prevent colds and the flu and method of using same
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
US6139864A (en) * 1998-04-28 2000-10-31 Sudzucker Aktiengesellschaft Compositions for common colds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EBY G A: "LINEARITY IN DOSE-RESPONSE FROM ZINC LOZENGES IN TREATMENT OF COMMON COLDS", JOURNAL OF PHARMACY TECHNOLOGY, CINCINNATI, OH, US, vol. 11, no. 3, 1 May 1995 (1995-05-01), pages 110 - 122, XP002056502, ISSN: 8755-1225 *

Also Published As

Publication number Publication date
US20070092552A1 (en) 2007-04-26
WO2004098566A2 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
HUS1500048I1 (en) Topical formulation of ivermectin for the treatment of dermatological conditions
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
AU2003291641A1 (en) Double gate semiconductor device having separate gates
WO2004113275A3 (en) Methods and compositions for treating amyloid-related diseases
WO2005046434A8 (en) Compositions and methods for diagnosing and treating mental disorders
BR0311285A (en) medical implant coating compositions and processes
AU2003235613A1 (en) Crude drug compositions for treating or preventing arthritic diseases and the preparation process
WO2006128022A3 (en) Solid compositions and methods for treating middle-of-the night insomnia
WO2004080391A3 (en) Novel antibacterial agents
CA2429020A1 (en) Use of cci-779 as an antineoplastic agent
MXPA05012901A (en) Clear, stable topical compositions of clarithromycin and processes for their preparation.
WO2004047792A3 (en) Liposomal glucocorticoids
WO2003011117A3 (en) Methods and compositions for treating and preventing distal bowel lesions
AU2003289330A1 (en) Preventives and/or remedies for central diseases
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2002323873A1 (en) Active ingredient combination of E.G. galanthamine or deoxypeganine and E.G. acamprosate or memantine for treating an addiction such as alcoholism
WO2003074006A3 (en) Compositions and methods for preventing sporadic neoplasia in colon
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
WO2004098566A3 (en) Chewable lozenge cold remedy composition and method for making same
EP1278234A3 (en) MOS transistor and method of manufacturing
SG116522A1 (en) Hatted polysilicon gate structure for improving salicide performance and method of forming the same.
GB2395602B (en) MOS transistor and method of manufacturing the same
WO2004078142A3 (en) Compositions and methods for preventing and treating endotoxin-related diseases and conditions
AU2003258176A1 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
WWE Wipo information: entry into national phase

Ref document number: 2007092552

Country of ref document: US

Ref document number: 10556739

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10556739

Country of ref document: US